AAAAAA

   
Results: 1-9 |
Results: 9
MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: TRENSCHEL R BERNIER M DELFORGE A MASSY M DEHEMRICOURT EL MAEREVOET M BADJOU R STRYCKMANS P BRON D
Citation: R. Trenschel et al., MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 325-352
INCIDENCE OF CMV INFECTION AND CMV DISEASE IN 100 ALLOGENIC TRANSPLANTED PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT
Authors: MEULEMAN N DEBRUYNE JM MAEREVOET M RIZOPOULO H ACKERMANS S BRON D
Citation: N. Meuleman et al., INCIDENCE OF CMV INFECTION AND CMV DISEASE IN 100 ALLOGENIC TRANSPLANTED PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT, Bone marrow transplantation, 21, 1998, pp. 489-489
EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA WITH AZTREONAM TEICOPLANIN IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - EXPERIENCE IN ONE SINGLE-CENTER
Authors: MEULEMAN N MAEREVOET M CRENIER L CROMBEZ P AOUN M BRON D
Citation: N. Meuleman et al., EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA WITH AZTREONAM TEICOPLANIN IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - EXPERIENCE IN ONE SINGLE-CENTER, Bone marrow transplantation, 21, 1998, pp. 541-541
CMV INFECTION AND DISEASE IN 100 ALLOGENEIC BMT PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT
Authors: BRON D MEULEMAN N DEBRUYNE JM MAEREVOET M RIZOPOULO H STRYCKMANS P
Citation: D. Bron et al., CMV INFECTION AND DISEASE IN 100 ALLOGENEIC BMT PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 208-209
LIMITED ACTIVITY OF MINI-DOSE INTERFERON ALPHA-2A IN THE TREATMENT OFMYELODYSPLASTIC SYNDROME
Authors: MAEREVOET M VANDENNESTE E DELANNOY A FERRANT A MARTIAT P BOSLY A FAUCHET M MICHAUX JL
Citation: M. Maerevoet et al., LIMITED ACTIVITY OF MINI-DOSE INTERFERON ALPHA-2A IN THE TREATMENT OFMYELODYSPLASTIC SYNDROME, Leukemia & lymphoma, 21(5-6), 1996, pp. 519-520
MYELOID AND LYMPHOID RECOVERY AFTER ALLOGENEIC RELATED, UNRELATED BONE-MARROW AND RELATED PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: TRENSCHEL R BERNIER M MASSY M MAEREVOET M DEHEMRICOURT EL DELFORGE A BADJOU R STRYCKMANS P BRON D
Citation: R. Trenschel et al., MYELOID AND LYMPHOID RECOVERY AFTER ALLOGENEIC RELATED, UNRELATED BONE-MARROW AND RELATED PERIPHERAL STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 3838-3838
CYCLOSPORINE-A IN THE TREATMENT OF REFRACTORY B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: VANDENNESTE E MAEREVOET M MARTIAT P FERRANT A DELANNOY A MICHAUX JL
Citation: E. Vandenneste et al., CYCLOSPORINE-A IN THE TREATMENT OF REFRACTORY B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Leukemia, 9(6), 1995, pp. 1102-1103
2-CHLORODEOXYADENOSINE (CDA) THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND WALDENSTROMS MACROGLOBULINEMIA (WD) - AN UPDATE ON 77 PATIENTS
Authors: MAEREVOET M DELANNOY A FERRANT A BOSLY A MARTIAT P MINEUR P CANON JL ZENEBERGH A MICHAUX JL
Citation: M. Maerevoet et al., 2-CHLORODEOXYADENOSINE (CDA) THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND WALDENSTROMS MACROGLOBULINEMIA (WD) - AN UPDATE ON 77 PATIENTS, Blood, 86(10), 1995, pp. 3338-3338
CYCLOSPORINE-A (CY A) HAS ONLY MARGINAL ANTILEUKEMIC ACTIVITY IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
Authors: VANDENNESTE E MAEREVOET M MARTIAT P FERRANT A DELANNOY A STRAETMANS N MICHAUX JL
Citation: E. Vandenneste et al., CYCLOSPORINE-A (CY A) HAS ONLY MARGINAL ANTILEUKEMIC ACTIVITY IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Blood, 84(10), 1994, pp. 10000659-10000659
Risultati: 1-9 |